US Patent Issued to In3Bio on April 7 for "Methods and compositions for inhibition of EGF/EGFR pathway in combination with tyrosine kinase inhibitors" (Belgian, Spanish Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,297, issued on April 7, was assigned to In3Bio Ltd. (Hamilton, Bermuda). "Methods and compositions for inhibition of EGF/EGFR pathway in co... Read More

US Patent Issued to XIYUAN ANJIAN MEDICINE (SHANGHAI) on April 7 for "Anti-NGF antibody and antigen-binding fragment thereof, preparation method, and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,298, issued on April 7, was assigned to XIYUAN ANJIAN MEDICINE (SHANGHAI) Co. LTD (Shanghai). "Anti-NGF antibody and antigen-binding fragme... Read More

US Patent Issued to Chugai Seiyaku on April 7 for "FC variants" (Japanese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,299, issued on April 7, was assigned to Chugai Seiyaku K.K. (Tokyo). "FC variants" was invented by Tomoyuki Igawa (Shizuoka, Japan), Atsuhi... Read More

US Patent Issued to Akeso Biopharma on April 7 for "Anti-human P40 protein domain antibody and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,300, issued on April 7, was assigned to Akeso Biopharma Inc. (Zhongshan, China). "Anti-human P40 protein domain antibody and use thereof" w... Read More

US Patent Issued to Pfizer, The Regents of the University of California, The Board of Trustees of the Leland Stanford Junior University on April 7 for "Anti-il-2 antibodies and compositions and uses thereof" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,301, issued on April 7, was assigned to Pfizer Inc. (New York), The Regents of the University of California (Oakland, Calif.) and The Board ... Read More

US Patent Issued to SANYOU BIOPHARMACEUTICALS on April 7 for "CLDN18.2 binding molecule" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,302, issued on April 7, was assigned to SANYOU BIOPHARMACEUTICALS Co. LTD. (Shanghai). "CLDN18.2 binding molecule" was invented by Yongcong... Read More

US Patent Issued to The General Hospital on April 7 for "Antibodies and chimeric antigen receptors that target TACI" (Massachusetts Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,303, issued on April 7, was assigned to The General Hospital Corp. (Boston). "Antibodies and chimeric antigen receptors that target TACI" w... Read More

US Patent Issued to STCube & Co. on April 7 for "Antibodies specific to glycosylated LAG3 and methods of use thereof" (Virginia Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,304, issued on April 7, was assigned to STCube & Co. Inc. (Seoul, South Korea). "Antibodies specific to glycosylated LAG3 and methods of us... Read More

US Patent Issued to Novartis on April 7 for "TREM2 stabilizing antibodies" (German, Swiss, French Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,305, issued on April 7, was assigned to Novartis AG (Basel, Switzerland). "TREM2 stabilizing antibodies" was invented by Verena Brand (Muni... Read More

US Patent Issued to Novartis on April 7 for "TREM2 stabilizing antibodies" (German, Swiss, French Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,306, issued on April 7, was assigned to Novartis AG (Basel, Switzerland). "TREM2 stabilizing antibodies" was invented by Verena Brand (Muni... Read More

• ««
• «
• 138534
• 138535
• 138536
• 138537
• 138538
• 138539
• 138540
• 138541
• 138542
• 138543
• »
• »»